
Develop a compliant cGMP training strategy by outlining induction, on-the-job, and SOP training, emphasizing health and hygiene, cross-contamination control, and data integrity, with solid documentation.
Learn quality risk management in pharma through proactive identification, risk assessment, and prioritization using RPN and FMEA, with practical cGMP process examples and mitigation planning.
Prepare for inspections by compiling the complete list and inventory of GXP computerized systems, validating them with a risk-based plan, and enforcing change control, training, data protection, and periodic reviews.
Interpret 21 CFR parts 210 and 211 and the eCFR, and apply cGMPs in pharma through case studies on training, doer and checker, gowning, and lighting and washing facilities.
Build a strong quality culture in pharma with a 21-step approach aligned to cGMP, EU GMP, US FDA, and PIC/S guidelines, emphasizing management accountability and open data integrity.
Establish a proactive quality culture in pharma by integrating management leadership, transparent deviation reporting, and continual improvement through variability investigations, risk management, and preventive actions.
Explore good behavior practices as the core of cGMP, highlighting how right attitude, proper gowning, accurate data handling, and proactive reporting prevent quality issues and data integrity breaches.
Explore the pharmaceutical quality system within current good manufacturing practices, detailing lifecycle elements, management responsibilities, and continual improvement through change control, corrective and preventive actions, and risk management.
Explore how to evaluate trends in GMP data to detect out-of-trend results, variability, and process drift. Apply training, trend-based CAPA, and regulatory guidelines (FDA Q7, Eudralex) for ongoing quality improvement.
Explore deviations in pharma under cGMP, using a risk-based categorization, investigations, root-cause analysis, and CAPA within a quality management system.
Adopt a pragmatic, compliance-driven change control approach within cgmp. Master life-cycle management, risk assessment, pdca cycles, and regulatory expectations from fda, ich, and who.
Explore corrective and preventive actions based on the poka-yoke principle in pharma cGMP, focusing on root-cause analysis, two-stage mistake-proofing, and practical examples.
As per FDA guide, (a) Each person engaged in the manufacture, processing, packing, or holding of a drug product shall have education, training, and experience, or any combination thereof, to enable that person to perform the assigned functions.
Training shall be in the particular operations that the employee performs and in current good manufacturing practice.
As per EU guide, The manufacturer should provide training for all the personnel whose duties take them into production and storage areas or into control laboratories (including the technical, maintenance and cleaning personnel), and for other personnel whose activities could affect the quality of the product.Besides the basic training on the theory and practice of the quality management system and Good Manufacturing Practice, newly recruited personnel should receive training appropriate to the duties assigned to them.
This training program is uniquely designed to comply the different regulatory expectations.
This program comprise of total 13 lectures. Which touches all the parts of GMPs like - Training requirements, Quality Risk management, inspection readyness for cGXP computerised systems, 21 CFR Part 210 and 211 with eCFR concept, Building quality culture with 21 steps appraoch and further how to establish the quality culture in the organisation, Good behavioural aspect of GMP training, Pharmaceutical quality system is very important when we discuss about the GMP training.
Further there are other topics with recorded sessions which includes - Quality management maturity (QMM) program by FDA, Most of the personnel prepares the trend but could not evaluate correctly. So, one topic is on evaluation of the trends.
After that there is separate topcis with recorded sessions on deviation, change control and CAPA.
This training session will cover complete cGMP requirements in about 12 hours of the lectures. Further more, if you have any question/s or need any clarification/s, please put your questions in comment section. I will respond you.